Reaction Details |
| Report a problem with these data |
Target | Fatty-acid amide hydrolase 1 |
---|
Ligand | BDBM359729 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | In Vitro Human FAAH Fluorescent Assay |
---|
IC50 | 0.890±n/a nM |
---|
Citation | Piomelli, D; Bandiera, T; Scarpelli, R Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments US Patent US10435355 Publication Date 10/8/2019 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Fatty-acid amide hydrolase 1 |
---|
Name: | Fatty-acid amide hydrolase 1 |
Synonyms: | Anandamide amidohydrolase | Anandamide amidohydrolase 1 | FAAH | FAAH1 | FAAH1_HUMAN | Fatty Acid Amide Hydrolase (FAAH) | Fatty-acid amide hydrolase (FAAH) | Fatty-acid amide hydrolase 1 | Oleamide hydrolase 1 |
Type: | Protein |
Mol. Mass.: | 63071.19 |
Organism: | Homo sapiens (Human) |
Description: | O00519 |
Residue: | 579 |
Sequence: | MVQYELWAALPGASGVALACCFVAAAVALRWSGRRTARGAVVRARQRQRAGLENMDRAAQ
RFRLQNPDLDSEALLALPLPQLVQKLHSRELAPEAVLFTYVGKAWEVNKGTNCVTSYLAD
CETQLSQAPRQGLLYGVPVSLKECFTYKGQDSTLGLSLNEGVPAECDSVVVHVLKLQGAV
PFVHTNVPQSMFSYDCSNPLFGQTVNPWKSSKSPGGSSGGEGALIGSGGSPLGLGTDIGG
SIRFPSSFCGICGLKPTGNRLSKSGLKGCVYGQEAVRLSVGPMARDVESLALCLRALLCE
DMFRLDPTVPPLPFREEVYTSSQPLRVGYYETDNYTMPSPAMRRAVLETKQSLEAAGHTL
VPFLPSNIPHALETLSTGGLFSDGGHTFLQNFKGDFVDPCLGDLVSILKLPQWLKGLLAF
LVKPLLPRLSAFLSNMKSRSAGKLWELQHEIEVYRKTVIAQWRALDLDVVLTPMLAPALD
LNAPGRATGAVSYTMLYNCLDFPAGVVPVTTVTAEDEAQMEHYRGYFGDIWDKMLQKGMK
KSVGLPVAVQCVALPWQEELCLRFMREVERLMTPEKQSS
|
|
|
BDBM359729 |
---|
n/a |
---|
Name | BDBM359729 |
Synonyms: | US10435355, Example 13 | US9822068, 13 | [3-(3-carbamoylphenyl)-2- fluoro-phenyl]N- cyclohexylcarbamate |
Type | Small organic molecule |
Emp. Form. | C20H21FN2O3 |
Mol. Mass. | 356.3907 |
SMILES | NC(=O)c1cccc(c1)-c1cccc(OC(=O)NC2CCCCC2)c1F |
Structure |
|